Williams Cancer Institute

Interleukin 6 Blockade a “Win-Win” for Cancer Immunotherapy

IL-6 blockade with Tocilizumab Increases Response to Cancer Immunotherapy While Reducing Side-Effects Though we have suspected that blocking IL-6 with immune checkpoint blockade could be helpful in cancer treatment, a new study on May 9, 2022, from MD Anderson, Hailemichael, et al. published titled “Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.” This sounds […]